兰卫医学
(301060)
| 流通市值：16.95亿 | | | 总市值：37.77亿 |
| 流通股本：1.80亿 | | | 总股本：4.01亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 555,933,149.05 | 756,195,014.87 | 722,119,049.85 | 665,812,821.35 |
| 应收票据及应收账款 | 1,371,643,811.99 | 1,679,507,542.99 | 1,977,602,054.02 | 2,249,422,440 |
| 其中：应收票据 | 21,513,439.78 | 19,233,827.73 | 20,843,730.14 | 25,979,804.34 |
| 应收账款 | 1,350,130,372.21 | 1,660,273,715.26 | 1,956,758,323.88 | 2,223,442,635.66 |
| 预付款项 | 20,154,949.97 | 14,104,775.31 | 16,584,471.92 | 15,649,662.31 |
| 其他应收款合计 | 8,877,436.17 | 7,860,250.28 | 8,251,192.54 | 11,830,667.93 |
| 存货 | 346,774,103.33 | 348,395,198.64 | 339,492,231.06 | 401,517,704.65 |
| 其他流动资产 | 50,108,140.73 | 37,171,043.28 | 32,716,090.69 | 44,355,102.28 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,453,491,591.24 | 2,843,233,825.37 | 3,096,765,090.08 | 3,388,588,398.52 |
| 非流动资产: | | | | |
| 长期股权投资 | 14,199,525.88 | 14,957,351.55 | 15,625,595.07 | 16,392,154.42 |
| 其他权益工具投资 | 347,107 | 347,107 | 347,107 | 347,107 |
| 固定资产 | 442,365,002.14 | 163,972,695.17 | 158,360,097.08 | 160,948,219.68 |
| 在建工程 | 16,737,201.71 | 8,380,327.78 | 1,964,042 | 0 |
| 使用权资产 | 20,670,005.78 | 51,447,778.95 | 55,939,828.52 | 60,010,655.92 |
| 无形资产 | 10,425,134.49 | 10,950,000.7 | 11,664,417.38 | 13,064,624.24 |
| 商誉 | 25,214,731.29 | 25,214,731.29 | 25,214,760.47 | 17,637,660.47 |
| 长期待摊费用 | 39,612,493.75 | 42,168,221.3 | 46,794,089.88 | 49,600,291.57 |
| 递延所得税资产 | 46,318,170.92 | 45,564,105.9 | 36,363,670.96 | 30,126,379.99 |
| 其他非流动资产 | 12,352,783.27 | 14,372,282.85 | 13,505,225.78 | 10,158,829 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 628,242,156.23 | 377,374,602.49 | 365,778,834.14 | 358,285,922.29 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,081,733,747.47 | 3,220,608,427.86 | 3,462,543,924.22 | 3,746,874,320.81 |
| 流动负债: | | | | |
| 短期借款 | 212,221,761.76 | 202,895,572.47 | 159,273,143.6 | 149,429,499.57 |
| 应付票据及应付账款 | 422,002,278.6 | 643,348,243.05 | 705,405,864.48 | 858,685,161.29 |
| 其中：应付票据 | 31,960,495.26 | 103,030,998.51 | 105,505,627.21 | 105,505,627.21 |
| 应付账款 | 390,041,783.34 | 540,317,244.54 | 599,900,237.27 | 753,179,534.08 |
| 合同负债 | 6,970,618.8 | 7,220,120.29 | 8,527,292.22 | 28,733,447.14 |
| 应付职工薪酬 | 33,176,319.66 | 31,989,663.66 | 115,653,668.13 | 219,916,704.45 |
| 应交税费 | 15,255,947.87 | 10,437,997.54 | 43,622,228.33 | 67,392,372.59 |
| 其他应付款合计 | 56,107,682.54 | 125,399,842.03 | 68,221,314.59 | 70,818,467.48 |
| 应付股利 | 5,880,000 | 74,481,992.4 | 5,880,000 | 5,880,000 |
| 一年内到期的非流动负债 | 21,396,713.09 | 15,943,766.86 | 16,195,132.7 | 16,814,655.56 |
| 其他流动负债 | 556,607.58 | 598,475.11 | 723,591.18 | 2,030,757.52 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 767,687,929.9 | 1,037,833,681.01 | 1,117,622,235.23 | 1,413,821,065.6 |
| 非流动负债: | | | | |
| 长期借款 | 145,895,000 | - | - | - |
| 应付债券 | - | - | - | 0 |
| 租赁负债 | 13,592,091.13 | 37,670,957.96 | 40,769,433.67 | 45,617,827.31 |
| 递延收益 | 12,893,391.08 | 13,467,681.68 | 14,048,590.37 | 14,680,910.09 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 172,380,482.21 | 51,138,639.64 | 54,818,024.04 | 60,298,737.4 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 940,068,412.11 | 1,088,972,320.65 | 1,172,440,259.27 | 1,474,119,803 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 400,517,000 | 400,517,000 | 400,517,000 | 400,517,000 |
| 资本公积 | 553,960,781.01 | 553,960,781.01 | 553,960,781.01 | 553,960,781.01 |
| 盈余公积 | 86,525,659.79 | 86,525,659.79 | 86,525,659.79 | 86,525,659.79 |
| 未分配利润 | 890,932,664.95 | 890,484,315.36 | 1,043,675,127.72 | 1,022,262,046.4 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,931,936,105.75 | 1,931,487,756.16 | 2,084,678,568.52 | 2,063,265,487.2 |
| 少数股东权益 | 209,729,229.61 | 200,148,351.05 | 205,425,096.43 | 209,489,030.61 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,141,665,335.36 | 2,131,636,107.21 | 2,290,103,664.95 | 2,272,754,517.81 |
| 负债和股东权益合计 | 3,081,733,747.47 | 3,220,608,427.86 | 3,462,543,924.22 | 3,746,874,320.81 |
| 公告日期 | 2023-10-28 | 2023-08-31 | 2023-04-27 | 2023-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |